/PRNewswire/ CarePredict today announced a $29M Series A-3 investment co-led by SV Health Investors Medtech Convergence Fund and Aspire Healthtech Partners..
/PRNewswire/ Nanopath Inc., a molecular diagnostics company enabling high-quality molecular testing in minutes, announced today that it has closed $10.